Search - tctmd.com

Displaying 21 - 40 of 83

Sort: Relevancy | Date

Presentation THT 2026

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Presenter: Jeffrey Testani

March 04, 2026

Presentation THT 2026

Supira Medical pVAD: Clinical Experience Beyond HR-PCI

Presenter: Gagan D. Singh

March 03, 2026

Presentation THT 2026

Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination

Presenter: Trejeeve Martyn

March 03, 2026

Presentation THT 2026

Early Clinical Experience with an Intravascular Ventricular Assist System: A Novel Approach to Ambulatory Support in Advanced Heart Failure

Presenter: Jeffrey Popma

March 03, 2026

Presentation THT 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Presenter: Jozef Bartunek

March 03, 2026

Presentation THT 2026

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Presenter: Rami Kahwash

March 03, 2026

Presentation THT 2026

Percutaneous MCS: The Clinician's Wish List

Presenter: Shelley Anne Hall

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT 2026

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

Presenter: Frailyn J. Nunez

March 03, 2026

Presentation THT 2026

UltraSight PVAD IQ Machine Learning Algorithm Accurately Identifies Impella Micro-axial Flow Pump Depth Across the Aortic Valve on Ultrasound Imaging: An Early Clinical Feasibility Study

Presenter: Luca Baldetti

March 03, 2026

Presentation THT 2026

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Presenter: Akshay Arora

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Presenter: Michele Esposito

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Presentation THT 2026

The Role of Provocative Hemodynamic Testing in Clinical Practice

Presenter: Susanna S. Mak

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Advertisement

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Supira Medical pVAD: Clinical Experience Beyond HR-PCI

Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination

Early Clinical Experience with an Intravascular Ventricular Assist System: A Novel Approach to Ambulatory Support in Advanced Heart Failure

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Percutaneous MCS: The Clinician's Wish List

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

UltraSight PVAD IQ Machine Learning Algorithm Accurately Identifies Impella Micro-axial Flow Pump Depth Across the Aortic Valve on Ultrasound Imaging: An Early Clinical Feasibility Study

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

The Role of Provocative Hemodynamic Testing in Clinical Practice

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content